Tonix Pharma ( (TNXP) ) has issued an update.
On February 27, 2025, Tonix Pharma Limited, a subsidiary of Tonix Pharmaceuticals Holding Corp., signed an employment agreement with Siobhan Fogarty, the Chief Technical Officer. The agreement includes an annual salary, bonus eligibility, and equity compensation, with a 180-day notice period for termination, reflecting standard industry practices.
More about Tonix Pharma
Tonix Pharmaceuticals Holding Corp. operates in the pharmaceutical industry, focusing on developing and commercializing innovative pharmaceutical products.
YTD Price Performance: -76.17%
Average Trading Volume: 1,627,104
Technical Sentiment Consensus Rating: Strong Buy
Current Market Cap: $43.94M
For a thorough assessment of TNXP stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
Questions or Comments about the article? Write to editor@tipranks.com